American Century Companies Inc. Acquires 97,030 Shares of HCA Healthcare, Inc. $HCA

American Century Companies Inc. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 192.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 147,539 shares of the company’s stock after acquiring an additional 97,030 shares during the period. American Century Companies Inc. owned 0.06% of HCA Healthcare worth $62,881,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in HCA Healthcare in the 2nd quarter valued at about $1,152,408,000. Pacer Advisors Inc. raised its position in shares of HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after purchasing an additional 896,437 shares during the period. Viking Global Investors LP increased its stake in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Mondrian Investment Partners LTD bought a new position in shares of HCA Healthcare in the third quarter valued at $106,605,000. Finally, HRT Financial LP acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth about $81,596,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In related news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 15,214 shares of company stock worth $7,797,595. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.5%

Shares of NYSE:HCA opened at $544.72 on Thursday. The company has a 50-day moving average price of $498.00 and a two-hundred day moving average price of $463.50. HCA Healthcare, Inc. has a twelve month low of $310.18 and a twelve month high of $552.90. The firm has a market capitalization of $121.81 billion, a PE ratio of 19.19, a P/E/G ratio of 1.66 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the firm earned $6.22 EPS. HCA Healthcare’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Analysts Set New Price Targets

A number of analysts have commented on the company. Sanford C. Bernstein set a $541.00 price objective on HCA Healthcare in a report on Monday, February 9th. Barclays upped their target price on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price on the stock. in a research note on Monday, December 15th. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Finally, Argus raised their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $534.50.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.